DK163689D0 - Peptidderivater - Google Patents

Peptidderivater

Info

Publication number
DK163689D0
DK163689D0 DK163689A DK163689A DK163689D0 DK 163689 D0 DK163689 D0 DK 163689D0 DK 163689 A DK163689 A DK 163689A DK 163689 A DK163689 A DK 163689A DK 163689 D0 DK163689 D0 DK 163689D0
Authority
DK
Denmark
Prior art keywords
peptide derivatives
peptide
derivatives
Prior art date
Application number
DK163689A
Other languages
English (en)
Other versions
DK163689A (da
Inventor
Rainer Albert
Wilfried Bauer
Francois Cardinaux
Janos Pless
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808275A external-priority patent/GB8808275D0/en
Priority claimed from GB888808528A external-priority patent/GB8808528D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK163689D0 publication Critical patent/DK163689D0/da
Publication of DK163689A publication Critical patent/DK163689A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK163689A 1988-04-08 1989-04-05 Peptidderivater DK163689A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808275A GB8808275D0 (en) 1988-04-08 1988-04-08 New calcitonin derivatives
GB888808528A GB8808528D0 (en) 1988-04-12 1988-04-12 Peptide derivatives

Publications (2)

Publication Number Publication Date
DK163689D0 true DK163689D0 (da) 1989-04-05
DK163689A DK163689A (da) 1989-10-30

Family

ID=26293749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK163689A DK163689A (da) 1988-04-08 1989-04-05 Peptidderivater

Country Status (19)

Country Link
US (1) US5541159A (da)
JP (2) JPH01305099A (da)
AT (1) ATA900689A (da)
AU (2) AU3362889A (da)
BE (1) BE1004357A4 (da)
CH (1) CH682152A5 (da)
DK (1) DK163689A (da)
ES (1) ES2015645A6 (da)
FR (1) FR2629825B1 (da)
GB (1) GB2218102B (da)
IE (1) IE930109L (da)
IL (1) IL89881A (da)
IT (1) IT1235894B (da)
LU (1) LU87495A1 (da)
MY (1) MY108554A (da)
NL (1) NL8900864A (da)
NZ (1) NZ228677A (da)
SE (1) SE8901241L (da)
WO (1) WO1989009786A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK163689A (da) * 1988-04-08 1989-10-30 Sandoz Ag Peptidderivater
DE3842010A1 (de) * 1988-12-14 1990-06-21 Hoechst Ag Kompetitive gonadoliberin-antagonisten
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
DK0477499T3 (da) * 1990-08-04 1994-05-30 Hoechst Ag Gonadoliberin-antagonister
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
EP0632813B1 (en) * 1992-02-13 1999-12-15 Torf Establishment Amadori reaction compounds and products, process for their manufacture, and their use
BR9305878A (pt) * 1992-02-13 1997-08-19 Torf Ets Compostos e produtos de reação de amadori processo para sua fabricação e seu uso
FR2695391B1 (fr) * 1992-09-04 1994-10-14 Centre Nat Rech Scient Glycopeptides, leur procédé d'obtention, et leurs applications biologiques.
EP0626170A3 (en) * 1993-05-10 1996-03-27 Sandoz Ltd Stabilization of pharmacoligically active compounds in controlled release compositions.
WO1994028015A1 (en) * 1993-05-20 1994-12-08 Biotech Australia Pty. Limited Lhrh antagonists
CA2168113C (en) * 1993-08-09 2002-10-01 Sun Hyuk Kim Therapeutic peptide derivatives
US5698672A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Synthetic calcitonin mimetics
US5698521A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Native calcitonin mimetics
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
US6239108B1 (en) 1996-07-11 2001-05-29 Biogen, Inc. Cell adhesion inhibitors
US6686350B1 (en) 1996-07-25 2004-02-03 Biogen, Inc. Cell adhesion inhibitors
JP2002515043A (ja) 1996-07-25 2002-05-21 バイオジェン，インコーポレイテッド Ｖｌａ―４インヒビターのための分子モデル
US6083480A (en) * 1997-05-01 2000-07-04 Diatide, Inc. Calcitonin receptor binding reagents
ES2356595T3 (es) * 1998-02-13 2011-04-11 Amylin Pharmaceuticals, Inc. Nuevos compuestos de actividad mixta de la amilina.
IL139967A (en) 1998-05-28 2005-11-20 Biogen Idec Inc Beta-alanine derivatives and pharmaceutical compositions containing the same
CN1377268A (zh) 1999-08-13 2002-10-30 比奥根公司 细胞粘合抑制剂
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US6875743B1 (en) 2000-11-28 2005-04-05 Biogen, Inc. Cell adhesion inhibitors
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7196112B2 (en) 2004-07-16 2007-03-27 Biogen Idec Ma Inc. Cell adhesion inhibitors
WO2010045342A1 (en) 2008-10-17 2010-04-22 Wisconsin Alumni Research Foundation Method of making biologically active alpha-beta peptides
GB201813677D0 (en) * 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
TW202320857A (zh) * 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956260A (en) * 1967-11-09 1976-05-11 Ciba-Geigy Corporation Hypocalcaemic peptides and processes for their manufacture
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
US4650854A (en) * 1985-06-06 1987-03-17 Usv Pharmaceutical Corporation Amide analogs of calcitonin
HUT44794A (en) * 1985-12-04 1988-04-28 Sandoz Ag Process for production of calcitonine-derivatives and medical preparatives containing such compounds
DE3634435A1 (de) * 1986-10-09 1988-04-14 Hoechst Ag Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols
DK163689A (da) * 1988-04-08 1989-10-30 Sandoz Ag Peptidderivater

Also Published As

Publication number Publication date
DK163689A (da) 1989-10-30
JPH01305099A (ja) 1989-12-08
GB2218102A (en) 1989-11-08
US5541159A (en) 1996-07-30
AU623385B2 (en) 1992-05-14
LU87495A1 (fr) 1989-11-14
IE930109L (en) 1989-10-08
CH682152A5 (da) 1993-07-30
ATA900689A (de) 1997-01-15
SE8901241L (sv) 1990-02-02
WO1989009786A1 (en) 1989-10-19
AU3362889A (en) 1989-11-03
JPH0789994A (ja) 1995-04-04
IT8947823A0 (it) 1989-04-07
NZ228677A (en) 1994-08-26
GB8907652D0 (en) 1989-05-17
AU3263789A (en) 1989-10-12
FR2629825A1 (fr) 1989-10-13
SE8901241D0 (sv) 1989-04-07
FR2629825B1 (fr) 1993-05-14
ES2015645A6 (es) 1990-09-01
IL89881A (en) 1994-05-30
IT1235894B (it) 1992-11-23
IL89881A0 (en) 1989-12-15
GB2218102B (en) 1992-09-16
BE1004357A4 (fr) 1992-11-10
MY108554A (en) 1996-10-31
NL8900864A (nl) 1989-11-01

Similar Documents

Publication Publication Date Title
DK612689D0 (da) Peptidderivater
DK163689A (da) Peptidderivater
DK22588D0 (da) Peptidderivater
DK532787D0 (da) Peptidderivater
DK540289D0 (da) Protein
DK149889D0 (da) Soedemiddel
DE68925161D1 (de) Alkylavermectin-Derivate
DE68927948D1 (de) Trehalosderivate
DK375789A (da) Peptidderivater
DK19789D0 (da) Dehydrocholcalciferolderivater
DK197989A (da) Peptidanaloger
DE68927657D1 (de) Butynylaminderivate
DK486089D0 (da) Pyranobenzoxadiazolderivater
DK301889A (da) Peptidderivater
DK395288D0 (da) Proteiner
DK177789D0 (da) Peptidderivater
FI91488B (fi) Seula
KR900700503A (ko) 펩티드
DK4390D0 (da) Peptidderivater
DE3824433A1 (de) Fluorcyclopropyl-derivate
DK160389A (da) Aryldionderivater
DK657189A (da) Peptidderivater
ATA155589A (de) Mitomycinphosphat-derivate
DK679488D0 (da) Peptidderivater
DK171489D0 (da) Peptidderivater

Legal Events

Date Code Title Description
PBP Patent lapsed
AHB Application shelved due to non-payment